Family of GTS Carry Packs handles drugs that patients self-administer
The “last mile” in pharma deliveries is usually considered to be from a warehouse to the pharmacy where it is dispensed to patients. But what about after that?—especially for products that patients self-administer while traveling themselves, or that call for storage in, say, a home refrigerator. The diabetes community is accustomed to convenience packages to carry a few insulin doses with them, but many of these packages are not designed to meet specific industry standards.
To address these and related concerns, Cool Chain Technologies (Holliston, MA) has introduced a line of products, the KoolTemp GTS Carry Packs, available in three sizes and with standard or advanced design features. Interior volumes range from 0.02 to 0.15 cu.ft.; all are rated for 2-8°C service, for up to 10 hours of thermal protection. The package’s refrigerant can be conditioned in a home refrigerator. “The advanced version specifically protects the product from low temperature shock making it easy to achieve an error‐free pack‐out. That is the difficult thing to protect against — thermal shock,” states TJ Rizzo, VP of sales and marketing.
The company notes that another potential use of the packages is for reps who are hand-carrying samples to physicians’ offices.
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
New UK Consortium Obtains $1.34M Grant to Launch Automated Cell Therapy Manufacturing Platform
July 15th 2025Cellular Origins, CGT Catapult, and Resolution Therapeutics partner up to design a fully automated, scalable CGT manufacturing solution, with the goal of accelerating patient access to cell therapies.
Study Connects COVID-19 Treatment Disparities to Gaps in Testing and Virtual Access
July 11th 2025New research finds that nearly half of the racial and ethnic disparities in outpatient COVID-19 antiviral prescriptions stem from encounter-level care barriers, such as limited access to rapid tests and telehealth, which emphasizes the need for systemic and practice-level reforms.